113 related articles for article (PubMed ID: 16627998)
1. Check, double check: the G2 barrier to cancer.
Foijer F; te Riele H
Cell Cycle; 2006 Apr; 5(8):831-6. PubMed ID: 16627998
[TBL] [Abstract][Full Text] [Related]
2. Mitogen requirement for cell cycle progression in the absence of pocket protein activity.
Foijer F; Wolthuis RM; Doodeman V; Medema RH; te Riele H
Cancer Cell; 2005 Dec; 8(6):455-66. PubMed ID: 16338659
[TBL] [Abstract][Full Text] [Related]
3. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
[TBL] [Abstract][Full Text] [Related]
4. In vivo significance of the G2 restriction point.
Foijer F; Delzenne-Goette E; Dekker M; Te Riele H
Cancer Res; 2007 Oct; 67(19):9244-7. PubMed ID: 17909031
[TBL] [Abstract][Full Text] [Related]
5. Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis.
Dou QP; An B; Will PL
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9019-23. PubMed ID: 7568064
[TBL] [Abstract][Full Text] [Related]
6. Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2.
Vormer TL; Foijer F; Wielders CL; te Riele H
Mol Cell Biol; 2008 Dec; 28(24):7263-73. PubMed ID: 18936168
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
8. Genetic instability as a consequence of inappropriate entry into and progression through S-phase.
Almasan A; Linke SP; Paulson TG; Huang LC; Wahl GM
Cancer Metastasis Rev; 1995 Mar; 14(1):59-73. PubMed ID: 7606822
[TBL] [Abstract][Full Text] [Related]
9. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
Wang Z; Hu H; Li G; Lee HJ; Jiang C; Kim SH; Lü J
Int J Cancer; 2008 Jan; 122(1):15-24. PubMed ID: 17847021
[TBL] [Abstract][Full Text] [Related]
10. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
11. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
[TBL] [Abstract][Full Text] [Related]
12. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.
Broude EV; Swift ME; Vivo C; Chang BD; Davis BM; Kalurupalle S; Blagosklonny MV; Roninson IB
Oncogene; 2007 Oct; 26(48):6954-8. PubMed ID: 17486059
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
[TBL] [Abstract][Full Text] [Related]
14. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
[TBL] [Abstract][Full Text] [Related]
15. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
[TBL] [Abstract][Full Text] [Related]
16. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
Dai XY; Zeng XX; Peng F; Han YY; Lin HJ; Xu YZ; Zhou T; Xie G; Deng Y; Mao YQ; Yu LT; Yang L; Zhao YL
Cell Physiol Biochem; 2012; 29(1-2):281-90. PubMed ID: 22415097
[TBL] [Abstract][Full Text] [Related]
17. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.
Bai M; Tsanou E; Skyrlas A; Sainis I; Agnantis N; Kanavaros P
Anticancer Res; 2007; 27(4B):2345-52. PubMed ID: 17695524
[TBL] [Abstract][Full Text] [Related]
19. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
20. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
